N

Neurocrine Biosciences
D

NBIX

135.540
USD
-1.03
(-0.75%)
مغلق
حجم التداول
89,453
الربح لكل سهم
5
العائد الربحي
-
P/E
36
حجم السوق
13,723,006,317
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ACAD
    -0.520
    (-2.99%)
    16.900 USD
    A
    ALKS
    -0.680
    (-2.21%)
    30.070 USD
    A
    AVDL
    -0.410
    (-3.82%)
    10.310 USD
    E
    ESPR
    -0.29500
    (-12.04%)
    2.15500 USD
    I
    INSM
    -3.890
    (-5.26%)
    70.000 USD
    S
    SAGE
    -0.22500
    (-4.27%)
    5.04000 USD
    S
    SRPT
    -5.630
    (-4.47%)
    120.200 USD
    TEVA
    TEVA
    0.315
    (1.51%)
    21.195 USD
    المزيد
الأخبار

العنوان: Neurocrine Biosciences

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.